1520O REGISTRI: Regorafenib in first-line of KIT/PDGFR wild type advanced GIST: Capatalize the A Spanish (GEIS), Italian (ISG) and French Sarcoma Group (FSG) phase II trial
Sign Up to like & getrecommendations! Published in 2021 at "Annals of Oncology"
DOI: 10.1016/j.annonc.2021.08.850
Abstract: Background: Around 15% of adult GIST are wild type for KIT/PDGFRA mutations (KPWT), usually have SDH deficiencies, and are resistant to imatinib (IM). The underlying mechanisms include overexpression of HIF1α in SDH deficient-GIST, high IGFR… read more here.
Keywords: invited speaker; research; interests institutional; institutional invited ... See more keywords
Invited Speaker Talks
Sign Up to like & getrecommendations! Published in 2023 at "American Journal of Reproductive Immunology"
DOI: 10.1111/aji.13695
Abstract: Autoimmune oophoritis and reproductive failures The immune system plays a critical role in ovarian function. Systemic proinflammatory conditions can affect folliculogenesis. The ovary is a frequent target of autoimmune attacks. The presence of lymphocytic oophoritis… read more here.
Keywords: speaker talks; autoimmune; invited speaker; immunology ... See more keywords